Nucleic Acid Isolation And Purification Industry Overview

The growing collaborations between different companies and organizations in the biotech industry is one of the factors driving the market. For instance, in March 2020, Zymo Research and Tecan partnered to introduce ready-to-use processing products that can streamline DNA or RNA extraction from COVID-19 specimens. The new DreamPrep NAP workstation assists laboratories to effectively and rapidly scale lab testing to provide a larger number of tests, consequently helping in mitigating the spread of the virus.     

The development of personalized medicine is another important factor that drives revenue generation in the market for nucleic acid isolation and purification. Next Generation Sequencing (NGS) is becoming increasingly popular in cancer tumor biopsies. Liquid biopsies are an attractive option for cancer diagnostics because the process employs a simple and routine test that can detect cancer at an early stage.

Gather more insights about the market drivers, restrains and growth of the Global Nucleic Acid Isolation And Purification market

Early diagnosis of cancer is the biggest challenge, and NGS can help effectively tackle the problem, increasing the demand for NGS technology. Therefore, an increase in the use of NGS technology is anticipated to directly impact the adoption of nucleic acid isolation and purification techniques.

Formalin-Fixed Paraffin-Embedded (FFPE) samples that are considered important in determining molecular correlates of carcinogenesis require labor-intensive nucleic acid purification for the sample, and such protocols also damage the nucleic acids. To combat such challenges companies are launching new extraction kits for efficient recovery of nucleic acids.

For instance, in March 2021, Purigen Biosystems, Inc. launched the Ionic FFPE Complete Purification Kit for recovering RNA/DNA from FFPE tissue samples in a single workflow. It helps in streamlining the workflow by reducing hands-on time by around 75% when compared to the manual column or bead-based methods. Hence, such advancements are further boosting the market growth.

Furthermore, the COVID-19 pandemic is acting as a positive catalyst for the growth of the market for nucleic acid isolation and purification. Researchers and companies across the world are focusing on developing specific assays and kits for rapid detection of SARS-CoV-2. For instance, in June 2020, Omega Bio-tek, Inc. launched Mag-Bind Viral RNA Xpress Kit for efficient and rapid isolation of viral RNA. In addition, the company also announced to have a production capacity of 6 million tests per month which brought a dramatic increase in the production capacities.

Browse through Grand View Research's Biotechnology Industry Research Reports.

• Clinical Diagnostics Market - The global clinical diagnostics market is anticipated to witness growth over the forecast period, driven by the development of sophisticated and specialized tests for early disease detection and disease management and increasing demand for lab automation.

• Genomics Market - The global genomics market size was valued at USD 20.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 15.35% from 2021 to 2028. The scientific community has tried to address genetic susceptibility and severity to SARS-CoV-2 infection by combining research efforts using existing genetic databases.

Nucleic Acid Isolation And Purification Market Segmentation

Grand View Research has segmented the global nucleic acid isolation and purification market based on product, type, method, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2017 - 2028)
  • Kits & Reagents
  • Instruments

• Type Outlook (Revenue, USD Million, 2017 - 2028)
  • DNA Isolation & Purification
    • Genomic DNA Isolation & Purification
    • Plasmid DNA Isolation & Purification
    • Viral DNA Isolation & Purification
    • Other
  • RNA Isolation & Purification
    • miRNA Isolation & Purification
    • mRNA Isolation & Purification
    • Total RNA Isolation & Purification
    • Other

• Method Outlook (Revenue, USD Million, 2017 - 2028)
  • Column-based
  • Magnetic Beads
  • Reagent-based
  • Others

• Application Outlook (Revenue, USD Million, 2017 - 2028)
  • Precision Medicine
  • Diagnostics
  • Drug Discovery & Development
  • Agriculture and Animal Research
  • Other Applications

• End-use Outlook (Revenue, USD Million, 2017 - 2028)
  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Hospitals and Diagnostic Centers
  • Other End-use

• Regional Outlook (Revenue, USD Million, 2017 - 2028)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)
  
  

Market Share Insights

• June 2021: Bio-Rad Laboratories (BIO) came out with quarterly revenue of $ 3.54 per share, beating Zacks Consensus Estimate of $ 1.90 per share. That compares with $ 1.61 per share last year. These figures are adjusted for non-repetitive items.
• January 2020: QIAGEN stated that it has completed 2,500 placements of its QIAsymphony instrument. These placements represent a great milestone for QIAGEN’s magnetic bead-based instruments.
  
  
  

Key Companies profiled:

Some prominent players in the global nucleic acid isolation and purification market include

• QIAGEN
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.  
• Danaher
• Hoffmann-La Roche AG
• Merck KGaA
• Agilent Technologies
• Bio-Rad Laboratories, Inc.
• Takara Bio, Inc.
• Promega Corporation
• New England Biolabs
• LGC Limited
• Abcam plc
• Norgen Biotek Corp
• AutoGen, Inc.
• Biogenuix
• PCR Biosystems, Inc.
• MagGenome
• Apical Scientific Sdn. Bhd
• MACHEREY-NAGEL GmbH & Co. KG

Order a free sample PDF of the nucleic acid isolation and purification Market Intelligence Study, published by Grand View Research.